Senior Counsel Thomas (T.J.) Ferrante was quoted in a Compliance Cosmos article, “FQHC Pays $300K to Put Telehealth Error to Rest; M.D.’s Name Was Not On List of Sites,” about a federally qualified health center (FQHC) in southeastern Ohio that agreed to pay nearly $300,000 to settle allegations that it billed Medicaid for telepsychiatry services from a site of service that was not on its “scope of project.”
Ferrante said one of the major telehealth mistakes he sees has to do with variations between state medical board rules and the payer source. “The provider may think they are in compliance because they know the medical board rules, but are actually in violation of the Medicaid program rules for reimbursement,” he said.
Ferrante said one of the major telehealth mistakes he sees has to do with variations between state medical board rules and the payer source. “The provider may think they are in compliance because they know the medical board rules, but are actually in violation of the Medicaid program rules for reimbursement,” he said.
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.